CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-2888PMID 26980766PMCID PMC4873401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mining CK2 in Cancer

  2014cited by this paper
• Platelet‐activating factor enhances tumour metastasis via the reactive oxygen species‐dependent protein kinase casein kinase 2‐mediated nuclear factor‐κB activation

  2014cited by this paper
• Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells

  2014cited by this paper
• Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.

  2014cited by this paper
• Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-RasV12 and Loss of p53

  2014cited by this paper
• Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

  2014cited by this paper
• Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction

  2013cited by this paper
• Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α′: implications for pathological roles of CK2 in promoting cancer cell survival

  2013cited by this paper
• CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells

  2013cited by this paper
• BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.

  2013cited by this paper
• SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma

  2012cited by this paper
• Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells

  2012cited by this paper
• Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ–inducible protein 10 in a casein kinase 2–dependent manner

  2012cited by this paper
• Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

  2012cited by this paper
• Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1

  2011influential reference
• Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.

  2011cited by this paper
• Monitoring tumor metastases and osteolytic lesions with bioluminescence and micro CT imaging.

  2011cited by this paper
• Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.

  2010cited by this paper
• Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma

  2010cited by this paper
• BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non‐small cell lung cancer

  2010cited by this paper
• TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts.

  2010cited by this paper
• Casein Kinase II: an attractive target for anti-cancer drug design.

  2010influential reference
• Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

  2010cited by this paper
• A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• Identification of Essential Sequences for Cellular Localization in BRMS1 Metastasis Suppressor

  2009influential reference
• Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.

  2009influential reference
• Protein kinase CK2, an important regulator of the inflammatory response?

  2008cited by this paper
• The Alpha Catalytic Subunit of Protein Kinase CK2 Is Required for Mouse Embryonic Development

  2007cited by this paper
• Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis

  2006influential reference
• A CK2-dependent mechanism for degradation of the PML tumor suppressor.

  2006cited by this paper
• NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells

  2006cited by this paper
• CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14‐3‐3s

  2006cited by this paper
• Isoform‐specific expression of 14‐3‐3 proteins in human lung cancer tissues

  2005cited by this paper
• Determining protein half-lives.

  2004cited by this paper
• The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

  2004cited by this paper
• CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

  2003cited by this paper
• CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response.

  2003cited by this paper
• Protein Kinase CK2 Promotes Aberrant Activation of Nuclear Factor-κB, Transformed Phenotype, and Survival of Breast Cancer Cells

  2002cited by this paper
• Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.

  2002cited by this paper
• Ras regulation of NF-kappa B and apoptosis.

  2001cited by this paper
• A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.

  2001cited by this paper
• Ras regulation of NF-KB and apoptosis

  2001cited by this paper
• Microdialysis: intraoperative and posttraumatic applications in neurosurgery.

  2001cited by this paper
• A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit α

  2001cited by this paper
• Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

  2000cited by this paper
• Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation*

  1999cited by this paper
• Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation.

  1999cited by this paper
• Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

  1999cited by this paper
• Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding.

  1999cited by this paper
• Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper

• CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions

  2025cites this paper
• Gene expression changes in pancreatic α-cell lines following knock-out Of either CK2α or CK2α’

  2025cites this paper
• Benchmarking computational tools for de novo motif discovery

  2024influential citation
• Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis

  2024cites this paper
• Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early‑stage lung adenocarcinoma.

  2024cites this paper
• CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling

  2024cites this paper
• Modeling lung adenocarcinoma metastases using patient-derived organoids

  2024cites this paper
• CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy.

  2024cites this paper
• 14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer

  2024cites this paper
• CSNK2A2 promotes Hepatocellular carcinoma progression through activation of NF-κB pathway.

  2023cites this paper
• Protein kinase CK2: An emerging regulator of cellular metabolism

  2023cites this paper
• Protein Kinase CK2α’, More than a Backup of CK2α

  2023influential citation
• BRMS1 in Gliomas—An Expression Analysis

  2023cites this paper
• A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos

  2022cites this paper
• CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

  2022cites this paper
• CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K–Akt pathway and epithelial–mesenchymal transition

  2022cites this paper
• CK2 and the Hallmarks of Cancer

  2022influential citation
• Inhibition of extracellular traps by spores of Trichoderma stromaticum on neutrophils obtained from human peripheral blood.

  2021cites this paper
• MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65

  2021cites this paper
• AKT inhibits the phosphorylation level of H2A at Tyr57 via CK2α to promote the progression of gastric cancer.

  2021cites this paper
• BRMS1: a multifunctional signaling molecule in metastasis

  2020influential citation
• Epigenetic mechanisms of anti-cancer effects of dietary stilbenoids

  2020cites this paper
• miR-17-5p regulates proliferation, invasion, migration and apoptosis of nasopha- ryngeal carcinoma CNE2 cells by down-regulating BRMS1L expression

  2019cites this paper
• Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

  2019cites this paper
• The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line.

  2019cites this paper
• MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.

  2019cites this paper
• Stilbenoid-mediated Epigenetic Activation of SEMAPHORIN 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.

  2019cites this paper
• Prediction of platinum‐resistance patients of gastric cancer using bioinformatics

  2019cites this paper
• BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis

  2018cites this paper
• BRMS1 participates in regulating cell sensitivity to DNA interstrand crosslink damage by interacting with FANCI.

  2018cites this paper
• Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival

  2017cites this paper
• For robust big data analyses: a collection of 150 important pro-metastatic genes

  2017cites this paper
• Inhibition of casein kinase 2 prevents growth of human osteosarcoma.

  2017cites this paper
• CK2α通过PI3K/Akt/GSK-3β信号通路调控肺腺癌A549细胞的侵袭及迁移

  2017cites this paper
• Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness.

  2017cites this paper
• The CK 2 inhibitor CX 4945 reverses cisplatin resistance in the A 549 / DDP human lung adenocarcinoma cell line

  year unknowncites this paper